|
Re: BETonMACE and Aminotransferases
|
5
|
Resverlogix Corp.
|
Aug 14, 2019 05:28PM
|
|
Re: Wow! What’s with the continued market drop?
|
5
|
Resverlogix Corp.
|
Sep 17, 2019 07:48PM
|
|
Re: New Share Price Contest
|
5
|
Resverlogix Corp.
|
Oct 11, 2019 02:34AM
|
|
Re: Zacks SCR 8/5/19: Targeting September Readout for BETonMACE
|
5
|
Resverlogix Corp.
|
Aug 06, 2019 03:30AM
|
|
Re: The runway is clear....
|
5
|
Resverlogix Corp.
|
Dec 08, 2018 03:02PM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
5
|
Resverlogix Corp.
|
Jan 10, 2018 12:31AM
|
|
Re: That's a Strong P Value....
|
5
|
Resverlogix Corp.
|
Feb 23, 2017 01:38PM
|
|
Re: Events
|
5
|
Zenith Epigenetics
|
Apr 26, 2017 12:31AM
|
|
Re: AAIC and MD&A
|
5
|
Resverlogix Corp.
|
Jul 25, 2018 03:08PM
|
|
Re: The runway is clear....
|
5
|
Resverlogix Corp.
|
Dec 08, 2018 04:09PM
|
|
Re: Beacon report
|
5
|
Resverlogix Corp.
|
Nov 17, 2017 01:16PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
5
|
Resverlogix Corp.
|
Mar 31, 2020 03:42PM
|
|
Re: Aureus
|
5
|
Resverlogix Corp.
|
Aug 20, 2018 01:25AM
|
|
Re: Zenith Payoff of Citi?
|
5
|
Resverlogix Corp.
|
Apr 05, 2017 08:48PM
|
|
Re: Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
5
|
Resverlogix Corp.
|
Nov 02, 2020 12:50PM
|
|
Re: A Wing and a Prayer
|
5
|
Resverlogix Corp.
|
Sep 21, 2019 03:59AM
|
|
Re: 0.05 P-values -- A bridge too far ?
|
5
|
Resverlogix Corp.
|
Feb 13, 2020 02:42AM
|
|
Re: Extension of debenture!
|
5
|
Resverlogix Corp.
|
Apr 20, 2022 09:47AM
|
|
Re: BETonMACE details
|
5
|
Resverlogix Corp.
|
May 17, 2018 12:16AM
|
|
Re: Article
|
5
|
Resverlogix Corp.
|
May 29, 2022 07:23PM
|
